Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 2 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Sakata Seed Corporation is currently navigating 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 7 actions are distributed among 6 distinct examiners, indicating that most examiners are handling individual cases while ZHONG, WAYNESHAOBIN manages multiple matters. This prosecution activity is concentrated technically, as the workload is located within only 2 distinct art units.
The busiest examiner for the portfolio is ZHONG, WAYNESHAOBIN, who is responsible for 2 busiest examiner pending office actions. The fact that the pending office actions are funneled into a limited number of art units suggests that Sakata Seed Corporation's innovations fall into specific biological or pharmaceutical categories. This concentration allows the company to develop a deep understanding of the specific examination trends and prior art preferences within the units.
With 6 distinct examiners involved, the company still faces a variety of individual perspectives, but the limited art unit count provides a more unified administrative environment than a more dispersed portfolio. By handling multiple pending actions, the busiest examiner represents a significant portion of the company's current USPTO interactions. Practitioners should note that the pending office actions are subject to the specific policies of these units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (29%) |
| §103 only | 1 (14%) |
| §112 only | 1 (14%) |
| Double-patenting + other | 2 (29%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHONG, WAYNESHAOBIN | 2 | 72.2% | +21.5% |
| IBRAHIM, MEDINA AHMED | 1 | 87.4% | +12.2% |
| PAGE, BRENT T | 1 | 82.4% | +10.8% |
| DELEO, VICTORIA LYNN | 1 | 41.4% | -44.4% |
| KINGDON, CATHY | 1 | 80.3% | +2.5% |
| BYRNES, DAVID R | 1 | 78.1% | +22.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19089575 | Cytoplasmic Male Sterile Brassica Rapa Plant Having Improved Growth Ability | PAGE, BRENT T | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19123805 | BROCCOLI PLANT THAT PRODUCES SMALL FLOWER BUDS WITH UNIFORM SIZE AND HIGH YIELD, AND METHOD FOR PRODUCING PROCESSED PRODUCT THEREOF | IBRAHIM, MEDINA AHMED | — |
| 18560069 | SPINACH PLANT HAVING NOVEL DOWNY MILDEW-RESISTANT GENE | DELEO, VICTORIA LYNN | — |
| 18037836 | CYTOPLASMIC MALE STERILE PLANT OF GENUS PETUNIA, INTERGENERIC HYBRID PLANT THEREOF, AND METHOD OF PRODUCING SAME | KINGDON, CATHY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18767320 | Inbred Broccoli line BP-1 | ZHONG, WAYNESHAOBIN | 19d overdue |
| 18767758 | Inbred Broccoli Line BP-2 | ZHONG, WAYNESHAOBIN | 18d overdue |
| 19123805 | BROCCOLI PLANT THAT PRODUCES SMALL FLOWER BUDS WITH UNIFORM SIZE AND HIGH YIELD, AND METHOD FOR PRODUCING PROCESSED PRODUCT THEREOF | IBRAHIM, MEDINA AHMED | — |
| 19089575 | Cytoplasmic Male Sterile Brassica Rapa Plant Having Improved Growth Ability | PAGE, BRENT T | — |
| 17604175 | CYTOPLASMIC MALE STERILE PLANT OF GENUS LACTUCA HAVING IMPROVED LOW TEMPERATURE GROWTH ABILITY | BYRNES, DAVID R | — |
| Art Unit | Apps |
|---|---|
| 1662 | 5 |
| 1663 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19123805 | BROCCOLI PLANT THAT PRODUCES SMALL FLOWER BUDS WITH UNIFORM SIZE AND HIGH YIELD, AND METHOD FOR PRODUCING PROCESSED PRODUCT THEREOF | IBRAHIM, MEDINA AHMED | 1662 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2025 |
| 19089575 | Cytoplasmic Male Sterile Brassica Rapa Plant Having Improved Growth Ability | PAGE, BRENT T | 1663 | §112 | Non-Final OA | — | Pending | Mar 25, 2025 |
| 18767758 | Inbred Broccoli Line BP-2 | ZHONG, WAYNESHAOBIN | 1662 | §112DP | Final Rejection | 18d overdue | Pending | Jul 09, 2024 |
| 18767320 | Inbred Broccoli line BP-1 | ZHONG, WAYNESHAOBIN | 1662 | §112DP | Final Rejection | 19d overdue | Pending | Jul 09, 2024 |
| 18560069 | SPINACH PLANT HAVING NOVEL DOWNY MILDEW-RESISTANT GENE | DELEO, VICTORIA LYNN | 1662 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18037836 | CYTOPLASMIC MALE STERILE PLANT OF GENUS PETUNIA, INTERGENERIC HYBRID PLANT THEREOF, AND METHOD OF PRODUCING SAME | KINGDON, CATHY | 1663 | §101§102§103§112 | Final Rejection | — | Pending | May 19, 2023 |
| 17604175 | CYTOPLASMIC MALE STERILE PLANT OF GENUS LACTUCA HAVING IMPROVED LOW TEMPERATURE GROWTH ABILITY | BYRNES, DAVID R | 1662 | §103 | Non-Final OA | — | Pending | Oct 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial